Olema Oncology logo

Senior Medical Director, Clinical Development

Olema Oncology
Remote friendly (Boston, MA)
United States
$315,000 - $350,000 USD yearly
Clinical Research and Development

Role Summary

Senior Medical Director, reporting to the SVP of Clinical Development, serving as the Oncology Physician Lead for palazestrant and driving advancement of Olema’s late-stage clinical pipeline. Guide registration-enabling studies by shaping study design, evaluating clinical data, and engaging with regulatory authorities, investigators, and key opinion leaders. Partner with cross-functional teams to ensure scientific rigor, data integrity, and patient-centric decision-making, while contributing to biomarker development, publication planning, and external scientific communications. Role based in San Francisco, CA or Cambridge, MA with up to 20% travel.

Responsibilities

  • Lead registration-enabling studies for palazestrant in combination with other therapies, including study design, regulatory engagement, and investigator collaboration
  • Partner across functions to define and implement clinical development strategies and plans for multiple programs
  • Serve as the primary medical expert and point of contact for clinical and scientific questions across internal and external stakeholders
  • Represent Olema in interactions with investigators, academic collaborators, thought leaders, and regulatory authorities
  • Maintain strong clinical and scientific acumen through ongoing engagement with the oncology community and key scientific meetings

Qualifications

  • Required: MD
  • Required: Board certification in Oncology, Hematology/Oncology, or related specialty; significant experience in breast cancer may substitute
  • Required: A minimum of 5+ years of direct biotech or pharmaceutical experience in clinical development, with leadership in late-phase studies
  • Preferred: Strong understanding of breast cancer treatment paradigms; experience with ER+/HER2- disease

Experience

  • Required: Proven success in designing, leading, and managing late-phase (registrational) studies in oncology; experience as a PI or academic breast cancer expert is valued
  • Required: Deep understanding of the drug development process and ability to translate strategy into action—meeting milestones, managing budgets, and adapting to change
  • Required: Strong knowledge of GCP, FDA, and EMA/CHMP regulations; familiarity with other global regulatory standards is advantageous
  • Required: Effective leadership in a matrixed environment, influencing without authority and driving cross-functional alignment
  • Required: Exceptional communication skills—able to convey complex clinical data with clarity and purpose to both scientific and non-scientific audiences
  • Required: Demonstrated problem-solving ability with urgency, focus, and creativity
  • Required: Proven record of building collaborative, high-performing teams and partnerships
  • Required: Highly organized, detail-oriented, and adaptable to fast-paced, evolving priorities

Additional Requirements

  • Travel up to 20%